Skip to main content
HR 5020 114th Congress House

Synthetic Drug Awareness Act of 2016

Official title: To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.

Introduced: April 21, 2016 Introduced by: Jeffries, Hakeem S. Democratic · New York See on congress.gov
Health Child healthCongressional oversightDrug trafficking and controlled substancesDrug, alcohol, tobacco use
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 22, 2016
Referred to the Subcommittee on Health.
Apr 21, 2016
Referred to the House Committee on Energy and Commerce.
Apr 21, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 22, 2016

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Synthetic Drug Awareness Act of 2016

This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").
 Related & companion bills 1
  • HR 449 Reintroduced Bill Synthetic Drug Awareness Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Republican 1
Donovan, Daniel
· Jul 11, 2016
Meehan, Patrick
· Jul 11, 2016
 R
Stefanik, Elise M.
New York · Jul 11, 2016
Gowdy, Trey
· Apr 21, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5020: Synthetic Drug Awareness Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5020/
MLA
"H.R. 5020: Synthetic Drug Awareness Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5020/.
Bluebook (legal)
H.R. 5020, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5020/.
Markdown link
[H.R. 5020: Synthetic Drug Awareness Act of 2016](https://openamerica.io/bill/114-HR-5020/)
Report a problem